Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berthold Fischer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|May 20, 2008
[Lung cancer]Berthold Fischer, Roland Buhl
Metal Ions in Biological Systems|March 27, 2002
Models for the pyranopterin-containing molybdenum and tungsten cofactorsBerthold Fischer, Sharon J Nieter Burgmayer
Inorganic Chemistry|October 24, 2001
Synthesis and Characterization of an Octanuclear Mixed-Ligand Copper(II) Complex of the Immunosuppressant Thiopurine Drug AzathioprineFu-chun Zhu Fc, Helmut W. Schmalle, Berthold Fischer, et al.
Oral Oncology|February 19, 2004
Ameloblastic fibrosarcoma or odontogenic carcinosarcoma: a matter of classification?Martin Kunkel, Maryam Ghalibafian, Herbert Radner, et al.
The Journal of Biological Chemistry|February 6, 2004
The tetrahydropyranopterin structure of the sulfur-free and metal-free molybdenum cofactor precursorJosé Angel Santamaria-Araujo, Berthold Fischer, Tanja Otte, et al.
Pneumologie (Stuttgart, Germany)|August 21, 2003
[Professor Dr. Rudolf Ferlinz 75 years of age]V Schulz, J Lorenz, H Steppling, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
c-kit expression in adenocarcinomas of the lungPatrick Micke, Jan Georg Hengstler, Heidi Albrecht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implicationsPatrick Micke, Maryam Basrai, Andreas Faldum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medizinische Klinik (Munich, Germany : 1983)|May 20, 2008
[Lung cancer]Berthold Fischer, Roland Buhl
Metal Ions in Biological Systems|March 27, 2002
Models for the pyranopterin-containing molybdenum and tungsten cofactorsBerthold Fischer, Sharon J Nieter Burgmayer
Inorganic Chemistry|October 24, 2001
Synthesis and Characterization of an Octanuclear Mixed-Ligand Copper(II) Complex of the Immunosuppressant Thiopurine Drug AzathioprineFu-chun Zhu Fc, Helmut W. Schmalle, Berthold Fischer, et al.
Oral Oncology|February 19, 2004
Ameloblastic fibrosarcoma or odontogenic carcinosarcoma: a matter of classification?Martin Kunkel, Maryam Ghalibafian, Herbert Radner, et al.
The Journal of Biological Chemistry|February 6, 2004
The tetrahydropyranopterin structure of the sulfur-free and metal-free molybdenum cofactor precursorJosé Angel Santamaria-Araujo, Berthold Fischer, Tanja Otte, et al.
Pneumologie (Stuttgart, Germany)|August 21, 2003
[Professor Dr. Rudolf Ferlinz 75 years of age]V Schulz, J Lorenz, H Steppling, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
c-kit expression in adenocarcinomas of the lungPatrick Micke, Jan Georg Hengstler, Heidi Albrecht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implicationsPatrick Micke, Maryam Basrai, Andreas Faldum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Phase II study of imatinib in patients with small cell lung cancerBruce E Johnson, Thomas Fischer, Berthold Fischer, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Pageof 2